All news (page 97)

23 February 2026

Sasol Advances Strategic Goals, Meets CMD Targets

Sasol reports stable turnover, improved production, and reduced costs. Despite lower earnings, free cash flow rose, supported by strategic initiatives and disciplined management.
23 February 2026

Novo Nordisk: CagriSema Shows 23% Weight Loss in Trial, Misses Primary Endpoint

CagriSema achieved 23% weight loss in 84 weeks but didn't match tirzepatide. Further trials will explore higher doses. Safe profile with mild gastrointestinal effects.
23 February 2026

AMAG Secures €75M EIB Loan for R&D Innovation

EIB's first TechEU loan in Austria supports digital and green advancements, boosting Europe's industrial base and securing critical raw materials.
23 February 2026

Covestro CEO Markus Steilemann to Step Down in 2028

CEO Markus Steilemann will not renew his contract beyond May 2028. The Supervisory Board will start a succession process, and Steilemann will ensure a smooth transition.
23 February 2026

Sasol Advances Strategic Goals, Meets CMD Targets

Despite a challenging macro environment, Sasol improved production, managed costs, and increased free cash flow, while advancing its Grow and Transform strategy.
21 February 2026

Johnson & Johnson's TREMFYA® Shows Sustained Remission in Ulcerative Colitis Over 3 Years

TREMFYA® maintains clinical, endoscopic, and histologic outcomes in ulcerative colitis through 140 weeks, with high patient retention and no new safety concerns.
21 February 2026

Geography Over Technology: Equinor’s H2M Eemshaven Hydrogen Project Collapsed

H2M Eemshaven was canceled because its location lacked pipeline links and local industrial demand. Underscores need for co-located infrastructure, policy support, and cluster sites.
20 February 2026

Chandra Asri Group reaches 50% completion of CA‑EDC plant

Chlor‑alkali/EDC plant hits 50% construction and aims for commercial start in Q1 2027; capacity 827,000 t caustic soda and 500,000 t EDC with import substitution and export value.
20 February 2026

Chugai Launches Japan's First Regenerative Treatment for Duchenne Muscular Dystrophy

ELEVIDYS, a one-time therapy for DMD, targets ambulatory patients aged 3-7. Safety measures and post-marketing studies are in place following reports of liver failure cases.
20 February 2026

Grupa Azoty Polyolefins Submits Restructuring Plan

A restructuring plan and proposals have been submitted to the National Register of Debtors, aiming for financial stability and a transaction with ORLEN.
20 February 2026

Eni Launches Ndungu Full-Field Offshore Angola

Ndungu full-field starts production offshore Angola, boosting output to 60,000 barrels/day. Part of Agogo IWH, it enhances Angola's oil capacity and aligns with low-carbon goals.
20 February 2026

RWE and Vestas Sign Turbine Deal for Vanguard West Offshore Wind Farm

92 turbines to power Vanguard West, with commissioning in 2029. Final investment decision expected in summer 2026. Project to power 1.5 million UK homes.
20 February 2026

EU Allocates €225M for Advanced Flu Vaccine Development

The EU funds next-gen flu vaccines to enhance protection, speed up development, and improve pandemic readiness through pre-commercial procurement.
20 February 2026

Umicore 2025 Full Year Results

Strong performance with €3.6B revenue, €847M EBITDA. Efficiency measures hit €100M target. Proposed €0.50/share dividend. Net debt at €1.4B, TRIR at 4.5.
20 February 2026

Uniper and GSPC Sign LNG Supply Deal

Starting 2028, up to 0.5 MTPA LNG will be delivered to India's west coast, enhancing energy ties and addressing supply-demand gaps.
20 February 2026

MGC Halts Construction at Dutch Facility

Construction of the MXDA facility in the Netherlands is discontinued due to cost, delays, and market conditions. Equipment removal is planned by 2029. Financial impacts are under review.
20 February 2026

Air Liquide Confirms 2025 Growth and Sets New Margin Goals

Record 2025 performance with increased sales, profits, and investments. New margin target for 2027 set. Dividend raised by 12.1%.
20 February 2026

Deutsche Infineum Develops Major Urban PV System in Germany

An 18MW PV system in Cologne will produce 18M kWh annually, aiding decarbonization and supporting local climate goals by 2027.
20 February 2026

Roche's Giredestrant NDA Accepted by FDA for Advanced Breast Cancer

FDA accepts giredestrant NDA based on phase III data showing reduced disease progression risk in ER-positive breast cancer. Decision expected by December 18, 2026.
20 February 2026

MOL Group Q4 2025 Results: Strong Downstream and Consumer Services Boost Performance

Upstream struggles amid tough conditions, while Downstream and Consumer Services thrive. Profit before tax drops 11% to USD 1.3B. 2026 guidance set at USD 1.5B.
20 February 2026

MOL Group Q4 and 2025 Results Released

Profit before tax fell 11% to USD 1.3B. Upstream faced challenges, while downstream grew. 2026 profit guidance set at USD 1.5B. Transition to holding structure and renewable expansion noted.
19 February 2026

Trafigura, Aurubis and Kamoa Copper complete first low‑carbon copper sale via Lobito Atlantic Railway

First shipment of low‑carbon copper anodes from the DRC routed via the Lobito Atlantic Railway to Europe, cutting inland transit to seven days.
19 February 2026

Statkraft transfers Silva Green Fuel technology to Silva Biofuel

Demo facility and HTL expertise transferred to a new company run by former employees; CEO named and investors invited to scale toward commercial plants; deal pending regulatory approval.
19 February 2026

Altris awarded EIC funding to industrialize sodium‑ion batteries

Secures €2.5M grant plus up to €10M equity to scale Prussian‑White sodium‑ion cathode production, expand European manufacturing, validate with industrial partners and accelerate commercial rollout.
19 February 2026

LanzaJet Secures $47M in New Funding, Valued at $650M

Existing investors boost LanzaJet's ATJ technology growth, supporting commercial deployment and securing feedstock supply through a multi-year tolling structure.
19 February 2026

Zenyaku's Rituxan Approved for Autoimmune Hemolytic Anemia Treatment

Rituxan gains approval for treating autoimmune hemolytic anemia, targeting B cells to reduce autoantibodies. Effective for warm AIHA, CAD, and PCH, offering an alternative to steroids.
19 February 2026

Technip Energies Appoints Jesse Stanley as President of Technologies & Products

Jesse Stanley joins as President, Technologies & Products, enhancing innovation and growth. The Executive Committee's new composition is announced.
19 February 2026

Asahi Kasei's Thin-Film Hall Elements Earn IEEE Milestone Recognition

Commercialized in 1983, thin-film Hall elements revolutionized magnetic sensors, enhancing electronics and energy efficiency, with over 50 billion units shipped globally.
19 February 2026

Infineum and RheinEnergie to Build Major Inner-City Solar Project in Cologne

An 18-megawatt solar installation in Cologne will generate 18 million kWh annually, aiding decarbonization and supporting local climate goals. Completion is set for 2027.
19 February 2026

Genentech's Venclexta and Acalabrutinib Combo Approved by FDA for Untreated CLL

FDA approves all-oral, fixed-duration regimen for CLL, reducing treatment time. AMPLIFY study shows 35% lower risk of progression or death compared to chemoimmunotherapy.

← Previous Next →